Humacyte Global, Inc.
Durham, NC Doing business as Humacyte
- UEI
- XRKCWCMCZKE7
- CAGE
- 47PM8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2525 NC-54, Durham, NC 27713, USA
- Website
- humacyte.com
- Founded
- 2004
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Phase 2 clinical trial | Medical Command | $4,025,472 | |
| Bioengineered blood vessels for vascular trauma: a pilot clinical study | Medical Command | $998,549 | |
| Thromboresistant small diameter tissue-engineered vascular grafts | National Institutes of Health | $217,277 | |
| Vascular interventions/innovations andtherapeutic advances (vita): bioengineeredgrafts for peripheral vascular disease… | National Heart Lung and Blood Institute | $1,570,756 | |
| Vascular prosthesis effort | Department of Defense | $4,031,367 |
Quick answers
What is Humacyte Global, Inc.'s UEI?
Humacyte Global, Inc.'s Unique Entity ID (UEI) in SAM.gov is XRKCWCMCZKE7.
What is Humacyte Global, Inc.'s CAGE code?
Humacyte Global, Inc.'s CAGE code is 47PM8.
What is Humacyte Global, Inc.'s primary NAICS code?
Humacyte Global, Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Where is Humacyte Global, Inc. located?
Humacyte Global, Inc.'s physical address in SAM.gov is 2525 NC-54, Durham, NC 27713, USA.
Is Humacyte Global, Inc. registered in SAM.gov?
Yes. Humacyte Global, Inc.'s SAM.gov registration is active through July 27, 2027.
What is Humacyte Global, Inc.'s most recent federal award?
Humacyte Global, Inc.'s most recent federal contract award is Phase 2 clinical trial (W81XWH17C0200), from Medical Command, on September 30, 2017.
On GovTribe
See Humacyte Global, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors